4
Changes in Ownership
Perspective Therapeutics, Inc. Filed Acc 0001437749-18-020969
Controller/Prin Fin&Acct Offic bought 2,452 shares at $0.41 ($1,005)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Austin Mark John Controller/Prin Fin&Acct Offic | 2018-11-13 | Purchase | +2,452 | $0.41 | $1,005 | 11,717 | D: show line 1 in the form |
| Open-market purchases · 2,452 sh · avg $0.41 · $1,005 | |||||||
Loading xslF345X03/rdgdoc.xml…